|
2024
|
Invention
|
Compounds and methods for kinase modulation, and indications therefor.
Compounds active on prote... |
|
2023
|
Invention
|
Synthesis of heterocyclic compounds.
Provided herein are intermediates and processes useful for ... |
|
2022
|
Invention
|
Compounds and methods for kinase modulation, and indications therefor. Compounds active on protei... |
|
|
Invention
|
Formulations of a compound modulating kinases.
Provided are solid dispersions of Compound I havi... |
|
2021
|
Invention
|
Compounds and methods for kras modulation and indications therefor.
Disclosed are compounds of F... |
|
|
Invention
|
Compounds and methods for kras modulation and indications therefor. Disclosed are compounds of Fo... |
|
|
Invention
|
Combinational drug anticancer therapies. Disclosed is a method of treating a subject suffering fr... |
|
|
Invention
|
Synthesis of heterocyclic compounds. Provided herein are intermediates and processes useful for f... |
|
|
Invention
|
Compounds and methods for cd73 modulation and indications therefor. Disclosed are compounds of Fo... |
|
|
Invention
|
Compounds and methods for csk modulation and indications therefor.
Disclosed are compounds of Fo... |
|
|
Invention
|
1,6-naphthyridine compounds and methods for csk modulation and indications therefor. Disclosed ar... |
|
2020
|
Invention
|
Compounds and methods for cd73 modulation and indications therefor.
Disclosed are compounds of F... |
|
|
Invention
|
Solid forms of a compound for modulating kinases.
Forms of 4-(6-(3,5-dimethylisoxazol-4-yl)-1-[(... |
|
|
Invention
|
Condensed azines for ep300 or cbp modulation and indications therefor. Disclosed are compounds of... |
|
2019
|
Invention
|
Compounds and methods for ido and tdo modulation, and indications therefor. Disclosed are compoun... |
|
2018
|
Invention
|
Formulations of a compound modulating kinases. Provided are solid dispersions of Compound I havin... |
|
|
Invention
|
Solid forms of a compound for modulating kinases. Forms of 4-(6-(3,5-dimethylisoxazol-4-yl)-1-[(1... |
|
|
Invention
|
Compounds modulating c-fms and/or c-kit activity and uses therefor.
Compounds active on the rece... |
|
|
Invention
|
Compositions and uses thereof.
Provided are solid dispersions, solid molecular complexes, salts ... |
|
|
Invention
|
Formulations of a compound modulating kinases. Provided are compositions comprising Compound I ha... |
|
|
Invention
|
Compounds and methods for kinase modulation. Disclosed are compounds having a compound of Formula... |
|
|
Invention
|
Crystalline forms of 4-(1-(1,1-di(pyridin-2-yl)ethyl)-6-(3,5-dimethylisoxazol-4-yl)-1h- pyrrolo[3... |
|
2017
|
Invention
|
Compounds and methods for cdk8 modulation and indications therefor. Disclosed are compounds of Fo... |
|
|
Invention
|
Compounds for kinase modulation, and indications therefor. Compounds active on protein kinases an... |
|
|
G/S
|
Pharmaceutical preparations and pharmaceutical products, namely, pharmaceutical compounds and pha... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cancer,
diabetes, and central nervous system, a... |
|
|
G/S
|
Product development research, product development, and product development consultation regarding... |
|
|
Invention
|
Compounds and methods for kinase modulation, and indications therefor.
Compounds and salts there... |
|
|
Invention
|
Compounds and methods for kinase modulation, and indications therefor. Compounds active on c-kit ... |
|
|
Invention
|
Compounds and methods for kinase modulation, and indications therefor. Disclosed are compounds of... |
|
|
Invention
|
Compounds and methods for kinase modulation and indications therefore. Disclosed are compounds of... |
|
2016
|
Invention
|
Heterocyclic compounds and uses thereof. Provided herein are heterocyclic compounds of Formula (I... |
